These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9915099)

  • 1. American Pharmaceutical Association review of literature on prescription to over-the-counter drug switches.
    Schulke DG
    Clin Ther; 1998; 20 Suppl C():C124-33. PubMed ID: 9915099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing pharmacists' preference for the legal classification of Rx-to-OTC switched drug products.
    Madhaven S
    J Clin Pharm Ther; 1993 Aug; 18(4):281-90. PubMed ID: 8227236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of vaginal antifungal products on utilization of health care services: evidence from physician visits.
    Lipsky MS; Waters T; Sharp LK
    J Am Board Fam Pract; 2000; 13(3):178-82. PubMed ID: 10826865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products.
    Gurwitz JH; McLaughlin TJ; Fish LS
    Health Serv Res; 1995 Dec; 30(5):672-85. PubMed ID: 8537226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: 2. Factors that may have influenced the marked changes in sales volumes during the 1990s.
    Mårdh PA; Wågström J; Landgren M; Holmén J
    Infect Dis Obstet Gynecol; 2004 Jun; 12(2):99-108. PubMed ID: 15739824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: I. Analyses of a unique database.
    Mårdh PA; Wågström J; Landgren M; Holmén J
    Infect Dis Obstet Gynecol; 2004 Jun; 12(2):91-7. PubMed ID: 15739823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of H2-receptor antagonists.
    Andrade SE; Gurwitz JH; Fish LS
    Med Care; 1999 Apr; 37(4):424-30. PubMed ID: 10213023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-based guidelines for non-prescription treatment of vulvovaginal candidiasis (VVC).
    Watson MC; Bond CM;
    Pharm World Sci; 2003 Aug; 25(4):129-34. PubMed ID: 12964489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of self-care with over-the-counter medications.
    Soller RW
    Clin Ther; 1998; 20 Suppl C():C134-40. PubMed ID: 9915100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women's use of over-the-counter antifungal medications for gynecologic symptoms.
    Ferris DG; Dekle C; Litaker MS
    J Fam Pract; 1996 Jun; 42(6):595-600. PubMed ID: 8656170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predicting the guideline compliant supply (or non-supply) of non-prescription medicines in the community pharmacy setting.
    Watson MC; Bond CM; Grimshaw J; Johnston M
    Qual Saf Health Care; 2006 Feb; 15(1):53-7. PubMed ID: 16456211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription to over-the-counter switches: the physician perspective.
    Byrns PJ
    Clin Ther; 1998; 20 Suppl C():C118-23. PubMed ID: 9915098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New OTC drugs and devices 2002: a selective review.
    Newton GD; Pray WS; Popovich NG
    J Am Pharm Assoc (Wash); 2003; 43(2):249-60. PubMed ID: 12688440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching from prescription to over-the counter medications: a consumer and managed care perspective.
    Pawaskar MD; Balkrishnan R
    Manag Care Interface; 2007 Jan; 20(1):42-7. PubMed ID: 17310652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New OTC drugs and devices 2001: a selective review.
    Newton GD; Benninghoff AJ; Pray WS; Popovich NG
    J Am Pharm Assoc (Wash); 2002; 42(2):267-77. PubMed ID: 11926667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Report of the 2013 APhA House of Delegates.
    J Am Pharm Assoc (2003); 2013; 53(4):365-7. PubMed ID: 23892807
    [No Abstract]   [Full Text] [Related]  

  • 18. The National Lipid Association surveys of consumers, physicians, and pharmacists regarding an over-the-counter statin in the United States: is this a good idea?
    McKenney JM; Brown WV; Cohen JD; Cahill E
    Am J Cardiol; 2004 Nov; 94(9A):16F-21F. PubMed ID: 15519287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of a switch from prescription to over-the-counter status for allergy drugs.
    Brass EP
    Curr Allergy Asthma Rep; 2004 May; 4(3):245-50. PubMed ID: 15056408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The costs and benefits of switching a drug from prescription-only to over-the-counter status: a review of methodological issues and current evidence.
    Andersson F; Hatziandreu E
    Pharmacoeconomics; 1992 Nov; 2(5):388-96. PubMed ID: 10147051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.